Institutional investors purchased a net $2.5 million shares of ADXS during the quarter ended January 2016 and now own 62.35% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SECTORAL ASSET MANAGEMENT, INC. Bought 383.3 Thousand shares of Advaxis Inc
FIDELITY MANAGEMENT & RESEARCH C... Bought 357.8 Thousand shares of Advaxis Inc